| Product Code: ETC13310127 | Publication Date: Apr 2025 | Updated Date: Aug 2026 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 190 | No. of Figures: 80 | No. of Tables: 40 |
| Market Size (2025) | USD 2 Billion |
| Forecast Size (2032) | USD 4.3 Billion |
| CAGR | 9.00% |
| Base Year | 2025 |
| Forecast Period | 2026-2032 |
| Largest Region | North America |
| Fastest Growing Region | Asia |
| Largest Segment | Endoscope |
| Fastest Growing Segment | Mechanical endoscopic equipment |
| Leading Companies | Boston Scientific, Medtronic, Olympus Corporation, Stryker, Johnson & Johnson |

The Global Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market was estimated at USD 2 Billion in 2025 and is projected to reach USD 4.3 Billion by 2032, growing at a CAGR of 9.00% from 2026 to 2032.
The Global Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market is undergoing a transformative phase fueled by an increasing prevalence of metabolic disorders, which necessitate effective management solutions. The shift towards minimally invasive procedures is not only changing the landscape of treatment modalities but also influencing clinical practices and patient preferences. A growing awareness among healthcare providers regarding endoscopic therapies is reshaping surgical strategies and enhancing patient outcomes.
Companies are actively pursuing research and development to enhance device functionality and precision in targeting obesity and related metabolic disorders. Different demographic segments are also emerging, with younger populations seeking preventative treatments. As a result, this market is becoming critical for supporting healthcare systems grappling with increasing obesity rates and associated comorbidities.
This graph illustrates the annual growth rates of the Global Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market from 2022 to 2032, highlighting a steady upward trajectory and projected expansion over the forecast period.

The table below presents the year‑wise growth rates along with the key drivers influencing the market
| Year | Growth Rate (%) | Major Drivers |
| 2022 | 10.08 | Manufacturers are actively engaging in M&A activity to strengthen endoscopy device offerings. |
| 2023 | 11.23 | Emerging technology companies are innovating endoscopy devices for obesity and diabetes treatment. |
| 2024 | 13.41 | Advanced biosensor technology is enhancing the supply chain for obesity-related diagnostic devices. |
| 2025 | 10.41 | Recent updates in reimbursement policy are facilitating greater access to endoscopy procedures. |
| 2026 | 11.65 | Promoting sustainable practices in manufacturing reduces environmental impact for endoscopy devices. |
| 2027 | 12 | Healthcare providers are utilizing enhanced workforce training to improve patient outcomes in diabetes care. |
| 2028 | 11.6 | In North America, growing awareness among patients increases demand for endoscopy procedures. |
| 2029 | 9.76 | As new competitors enter the market, established firms are refining their endoscopy device strategies. |
| 2030 | 12 | A comprehensive expansion of geographic reach improves accessibility of endoscopy devices for NASH treatment. |
| 2031 | 13.89 | Rising raw material costs are influencing the pricing structure of endoscopy devices in healthcare. |
| 2032 | 10.05 | A shift toward telehealth platforms changes how patients access endoscopy for obesity management. |
Note - Market size estimations and growth projections presented in this report are based on 6Wresearch's proprietary research methodology, combining internal industry data, secondary research, and primary validation, updated periodically to reflect current market conditions. As markets evolve rapidly, figures for certain industries may vary slightly and are intended as informed estimates rather than absolute figures. For the most current market sizing, we recommend validating figures with a 6Wresearch analyst.
Below are some of the specific key takeaways from the market, including:
Despite the promising growth of the Global Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market, several restraints pose significant challenges. High costs associated with advanced endoscopic devices can be prohibitive; for instance, some devices can exceed USD 100,000, which limits accessibility in emerging markets. Additionally, regulatory hurdles linked to device approvals can further delay market entry. For example, the FDA's premarket approval process can take several months, creating barriers for manufacturers aiming to introduce innovative solutions efficiently.
A notable trend shaping the market is the integration of AI in endoscopic procedures. Companies like Medtronic have begun to implement AI-driven analytics to enhance diagnostic accuracy during endoscopic surgeries, delivering greater precision in real-time. This evolution is accompanied by a marked increase in the demand for visualization and documentation systems—transforming procedures into more informative and efficient processes. Moreover, the expansion of endoscopic sleeve gastroplasty is becoming increasingly popular as a non-invasive weight loss solution, demanding further innovation in device technology.
Significant opportunities lie within the untapped potential of endoscopic devices dedicated to Type II diabetes. Companies such as Boston Scientific are exploring the development of new therapies tailored to metabolic management. For instance, novel endoscopic techniques targeting metabolic pathways are projected to capture an emerging share of the market, estimated to be valued at more than USD 800 million by 2032. Additionally, the surge in preventive healthcare measures provides a strong foundation for growth, with patients increasingly seeking outpatient options that require fewer resources than traditional surgery.
The leading segment in the Global Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market is the Endoscope, holding a substantial share of approximately 42% in 2025, driven by its integral role in various procedures. Meanwhile, mechanical endoscopic equipment is the fastest-growing segment, projected to achieve a CAGR of 11.0% from 2026 to 2032. This growth is attributed to advancements in device designs that enhance procedural efficiency and patient safety, contributing to wider adoption across healthcare settings.
Among the various procedures, Gastric balloon remains the largest segment, commanding approximately 40% share in 2025, largely due to its established efficacy and patient acceptance. In stark contrast, the fastest-growing procedure is Endoscopic sleeve gastroplasty, which is projected to experience a CAGR of 12.3% from 2026 to 2032. This rapid growth is fueled by its non-invasive nature and promising outcomes, attracting both patients and clinicians.
In the context of disease indications, Obesity dominates the market with a share of 55% in 2025, reflecting its widespread prevalence. Conversely, Nonalcoholic Steatohepatitis (NASH) is the fastest-growing indication, expected to expand at a CAGR of 10.5% from 2026 to 2032, as awareness of this condition increases and treatment options improve, driving demand for specialized endoscopic solutions.
North America is currently the largest region in the Global Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market, accounting for approximately 45% of market share in 2025, attributed to robust healthcare infrastructure and high prevalence of obesity. Conversely, the Asia region is set to be the fastest-growing, projected to grow at a CAGR of 10.2% from 2026 to 2032. This growth is largely supported by increasing healthcare expenditure and rising patient awareness of endoscopic procedures.
Regulatory support and policy initiatives play a crucial role in shaping the Global Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market. Various government bodies are introducing measures to enhance access and drive innovation within this sector.
The evolving dynamics of the Global Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market will be heavily influenced by innovations in minimally invasive techniques and digital health solutions. For instance, in 2022, Medtronic implemented advanced imaging technologies that enhance procedural accuracy, setting a benchmark for subsequent device developments. As these procedures gain wider acceptance, there will likely be an influx of new therapies targeting metabolic disorders, reflecting a shift towards greater patient involvement and preventative care strategies by 2032.
Recent commercial activities demonstrate a commitment to enhancing product offerings and technology integration within the market. Below are key developments:
The competitive landscape of the Global Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market is characterized by a mix of consolidated and fragmented players. Leading companies are increasingly focusing on strategic partnerships, technological advancements, and expanding product portfolios to capture greater market share.
| Leading Company | Core Strength | Strategic Focus |
|---|---|---|
| Boston Scientific | Expertise in advanced therapeutic devices. | Innovation in endoscopic interventions for obesity. |
| Medtronic | Leadership in minimally invasive surgical technologies. | Integration of AI and digital health solutions. |
| Olympus Corporation | Strong presence in imaging and optics technology. | Enhancement of training and educational resources. |
| Stryker | Robust robotics and surgical device portfolio. | Focus on partnerships for technological integration. |
| Johnson & Johnson | Diverse range of healthcare products and solutions. | Expansion into emerging markets and innovative treatments. |
As competition intensifies, companies will need to emphasize unique value propositions while fostering partnerships to innovate and improve clinical outcomes.
Global Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Global Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Overview |
3.1 Global Regional Macro Economic Indicators |
3.2 Global Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Revenues & Volume, 2022 & 2032F |
3.3 Global Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market - Industry Life Cycle |
3.4 Global Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market - Porter's Five Forces |
3.5 Global Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Revenues & Volume Share, By Regions, 2022 & 2032F |
3.6 Global Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Revenues & Volume Share, By Product, 2022 & 2032F |
3.7 Global Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Revenues & Volume Share, By Procedure, 2022 & 2032F |
3.8 Global Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Revenues & Volume Share, By Disease Indication, 2022 & 2032F |
4 Global Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Global Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Trends |
6 Global Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market, 2022-2032 |
6.1 Global Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market, Revenues & Volume, By Product, 2022-2032 |
6.1.1 Overview & Analysis |
6.1.2 Global Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market, Revenues & Volume, By Endoscope, 2022-2032 |
6.1.3 Global Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market, Revenues & Volume, By Mechanical endoscopic equipment, 2022-2032 |
6.1.4 Global Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market, Revenues & Volume, By Visualization and documentation systems, 2022-2032 |
6.1.5 Global Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market, Revenues & Volume, By Accessories, 2022-2032 |
6.1.6 Global Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market, Revenues & Volume, By Other endoscopy equipment , 2022-2032 |
6.2 Global Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market, Revenues & Volume, By Procedure, 2022-2032 |
6.2.1 Overview & Analysis |
6.2.2 Global Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market, Revenues & Volume, By Gastric balloon, 2022-2032 |
6.2.3 Global Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market, Revenues & Volume, By Aspiration therapy, 2022-2032 |
6.2.4 Global Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market, Revenues & Volume, By Endoscopic sleeve gastroplasty, 2022-2032 |
6.2.5 Global Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market, Revenues & Volume, By Gastric injection, 2022-2032 |
6.2.6 Global Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market, Revenues & Volume, By Lap band surgery , 2022-2032 |
6.3 Global Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market, Revenues & Volume, By Disease Indication, 2022-2032 |
6.3.1 Overview & Analysis |
6.3.2 Global Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market, Revenues & Volume, By Obesity , 2022-2032 |
6.3.3 Global Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market, Revenues & Volume, By Type II Diabetes , 2022-2032 |
6.3.4 Global Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market, Revenues & Volume, By Nonalcoholic Steatohepatitis (NASH, 2022 - 2032 |
7 North America Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market, Overview & Analysis |
7.1 North America Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Revenues & Volume, 2022-2032 |
7.2 North America Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market, Revenues & Volume, By Countries, 2022-2032 |
7.2.1 United States (US) Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market, Revenues & Volume, 2022-2032 |
7.2.2 Canada Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market, Revenues & Volume, 2022-2032 |
7.2.3 Rest of North America Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market, Revenues & Volume, 2022-2032 |
7.3 North America Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market, Revenues & Volume, By Product, 2022-2032 |
7.4 North America Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market, Revenues & Volume, By Procedure, 2022-2032 |
7.5 North America Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market, Revenues & Volume, By Disease Indication, 2022-2032 |
8 Latin America (LATAM) Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market, Overview & Analysis |
8.1 Latin America (LATAM) Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Revenues & Volume, 2022-2032 |
8.2 Latin America (LATAM) Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market, Revenues & Volume, By Countries, 2022-2032 |
8.2.1 Brazil Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market, Revenues & Volume, 2022-2032 |
8.2.2 Mexico Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market, Revenues & Volume, 2022-2032 |
8.2.3 Argentina Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market, Revenues & Volume, 2022-2032 |
8.2.4 Rest of LATAM Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market, Revenues & Volume, 2022-2032 |
8.3 Latin America (LATAM) Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market, Revenues & Volume, By Product, 2022-2032 |
8.4 Latin America (LATAM) Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market, Revenues & Volume, By Procedure, 2022-2032 |
8.5 Latin America (LATAM) Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market, Revenues & Volume, By Disease Indication, 2022-2032 |
9 Asia Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market, Overview & Analysis |
9.1 Asia Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Revenues & Volume, 2022-2032 |
9.2 Asia Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market, Revenues & Volume, By Countries, 2022-2032 |
9.2.1 India Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market, Revenues & Volume, 2022-2032 |
9.2.2 China Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market, Revenues & Volume, 2022-2032 |
9.2.3 Japan Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market, Revenues & Volume, 2022-2032 |
9.2.4 Rest of Asia Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market, Revenues & Volume, 2022-2032 |
9.3 Asia Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market, Revenues & Volume, By Product, 2022-2032 |
9.4 Asia Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market, Revenues & Volume, By Procedure, 2022-2032 |
9.5 Asia Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market, Revenues & Volume, By Disease Indication, 2022-2032 |
10 Africa Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market, Overview & Analysis |
10.1 Africa Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Revenues & Volume, 2022-2032 |
10.2 Africa Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market, Revenues & Volume, By Countries, 2022-2032 |
10.2.1 South Africa Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market, Revenues & Volume, 2022-2032 |
10.2.2 Egypt Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market, Revenues & Volume, 2022-2032 |
10.2.3 Nigeria Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market, Revenues & Volume, 2022-2032 |
10.2.4 Rest of Africa Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market, Revenues & Volume, 2022-2032 |
10.3 Africa Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market, Revenues & Volume, By Product, 2022-2032 |
10.4 Africa Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market, Revenues & Volume, By Procedure, 2022-2032 |
10.5 Africa Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market, Revenues & Volume, By Disease Indication, 2022-2032 |
11 Europe Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market, Overview & Analysis |
11.1 Europe Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Revenues & Volume, 2022-2032 |
11.2 Europe Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market, Revenues & Volume, By Countries, 2022-2032 |
11.2.1 United Kingdom Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market, Revenues & Volume, 2022-2032 |
11.2.2 Germany Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market, Revenues & Volume, 2022-2032 |
11.2.3 France Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market, Revenues & Volume, 2022-2032 |
11.2.4 Rest of Europe Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market, Revenues & Volume, 2022-2032 |
11.3 Europe Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market, Revenues & Volume, By Product, 2022-2032 |
11.4 Europe Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market, Revenues & Volume, By Procedure, 2022-2032 |
11.5 Europe Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market, Revenues & Volume, By Disease Indication, 2022-2032 |
12 Middle East Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market, Overview & Analysis |
12.1 Middle East Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Revenues & Volume, 2022-2032 |
12.2 Middle East Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market, Revenues & Volume, By Countries, 2022-2032 |
12.2.1 Saudi Arabia Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market, Revenues & Volume, 2022-2032 |
12.2.2 UAE Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market, Revenues & Volume, 2022-2032 |
12.2.3 Turkey Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market, Revenues & Volume, 2022-2032 |
12.3 Middle East Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market, Revenues & Volume, By Product, 2022-2032 |
12.4 Middle East Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market, Revenues & Volume, By Procedure, 2022-2032 |
12.5 Middle East Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market, Revenues & Volume, By Disease Indication, 2022-2032 |
13 Global Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Key Performance Indicators |
14 Global Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market - Export/Import By Countries Assessment |
15 Global Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market - Opportunity Assessment |
15.1 Global Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Opportunity Assessment, By Countries, 2022 & 2032F |
15.2 Global Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Opportunity Assessment, By Product, 2022 & 2032F |
15.3 Global Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Opportunity Assessment, By Procedure, 2022 & 2032F |
15.4 Global Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Opportunity Assessment, By Disease Indication, 2022 & 2032F |
16 Global Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market - Competitive Landscape |
16.1 Global Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Revenue Share, By Companies, 2025 |
16.2 Global Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Competitive Benchmarking, By Operating and Technical Parameters |
17 Top 10 Company Profiles |
18 Recommendations |
19 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here